Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash Flows from Operating Activities
Net loss	$ (1,281,108)	$ (477,121)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation	6,029	5,708
Stock based compensation, including amortization of prepaid fees	23,666	14,688
Amortization of original issue discount and debt discount on convertible notes	154,835	72,044
Financing cost	192,062
Change in fair value of derivative financial instrument	14,621
Loss on extinguishment of debt	325,223
Change in fair value of debt	57,946
Changes in operating assets and liabilities:
Accounts receivable	(36,174)	18,243
Prepaid expenses and deposits	12,575	9,704
Accounts payable and accrued expenses	90,336	23,783
Due to related party, current portion	15,835	7,761
Net cash used in operating activities	(424,154)	(325,190)
Cash Flows from Investing Activities
Acquisition of property and equipment	(201)	(5,147)
Net cash used in investing activities	(201)	(5,147)
Cash Flows from Financing Activities
Proceeds from sale of common stock	251,568	210,000
Proceeds from issuance of convertible notes	325,000
Repayment of convertible notes	(209,682)
Proceeds from related party loans	101,450	135,000
Repayment of related party loans	(9,000)	(11,192)
Repayment of notes payable and bank loans	(52,619)
Payments on capital leases	(3,058)	(4,587)
Net cash provided by financing activities	403,659	329,221
Net increase (decrease) in cash	(20,696)	(1,116)
Cash, beginning of period	50,006	58,716
Cash, end of period	29,310	57,600
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	7,117	457
Cash paid during the period for income tax
Schedule of non-cash investing and financing activities:
Fair value of warrants issued to extend maturity date of convertible notes payable, recognized as discount against convertible notes payable	10,199	7,506
Fair value of beneficial conversion feature and original issue discount allocated to proceeds of convertible notes payable	517,062
Common stock issuable issued during period	8
Derivative liabilities written off with repayment of convertible notes payable	160,850
Fair value of warrants issued to extend related party notes payable	337,466
Fair value of warrants issued pursuant to Amended Investment Agreement		$ 56,635